New Zealand markets closed

WuXi Biologics (Cayman) Inc (1FW2.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
1.3928-0.0114 (-0.81%)
At close: 09:05PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
17,034,255
17,034,255
15,268,660
10,290,050
5,612,384
-
Cost of revenue
10,206,354
10,206,354
8,544,646
5,461,153
3,079,418
-
Gross profit
6,827,901
6,827,901
6,724,014
4,828,897
2,532,966
-
Operating expenses
Research development
785,822
785,822
682,818
501,583
303,734
-
Selling general and administrative
1,789,361
1,789,361
1,432,505
1,000,579
605,851
-
Total operating expenses
2,377,704
2,377,704
1,925,659
1,364,232
771,431
-
Operating income or loss
4,450,197
4,450,197
4,798,355
3,464,665
1,761,535
-
Interest expense
158,488
158,488
64,382
39,191
42,732
-
Income before tax
4,173,803
4,173,803
5,357,771
3,993,119
1,965,760
-
Income tax expense
603,179
603,179
807,865
484,538
273,066
-
Income from continuing operations
3,570,624
3,570,624
4,549,906
3,508,581
1,692,694
-
Net income
3,399,729
3,399,729
4,420,286
3,388,478
1,688,886
-
Net income available to common shareholders
3,399,729
3,399,729
4,420,286
3,388,478
1,688,886
-
Basic EPS
1.00
-
1.06
0.81
0.43
0.27
Diluted EPS
0.95
-
1.01
0.77
0.40
0.25
Basic average shares
4,163,889
-
4,172,736
4,173,681
3,952,964
3,717,120
Diluted average shares
4,357,661
-
4,375,908
4,421,797
4,209,169
3,997,125